Medicare-for-All Bill Has Little Chance of Passage in Congress, Even as Universal Healthcare Debate Gains Momentum Among Democratic Presidential Hopefuls

Massive government takeover of healthcare would create single-payer healthcare system, doing away with Medicare Advantage and individual choice All clinical laboratories and anatomic pathology groups have a strong interest in how any reform of US healthcare at the federal level might be accomplished. In that spirit, Dark Daily is providing a quick overview of the Medicare for All Act of 2019 (HR 1384). The name is misleading. The bill would actually end Medicare and all private health...

Analytics Help Clinical Laboratories Minimize Risk and Remain Innovative as Esoteric and Molecular Testing Markets Grow

Data-driven proof supports decision-making that optimizes efficiency and boosts bottom lines in the face of shrinking margins and increased competition Molecular and esoteric testing developers continue to make advanced assays and diagnostic technologies available to medical laboratories. However, some laboratory senior management and stakeholders may be reluctant to invest in them even though the market for such testing is poised for significant growth. That’s because lab shareholders might...

Scientific Paper on Private Equity Ownership in Dermatology is Removed from Peer-Reviewed Medical Journal’s Website After Dermatologists Complain

The paper’s authors stand by their research and claim “requested corrections” were to protect reputations and not correct inaccuracies Private equity companies have invested in and acquired clinical laboratories and anatomic pathology groups for the past 25 years. It’s not unusual to find private equity firms buying other medical specialty practices as well. But questioning the reasons behind such acquisitions by private corporations, or physicians’ participation in such practices is,...

Many Hospital Laboratories Must Report PAMA Private Payer Clinical Lab Test Price Data as ‘Applicable Labs’ in 2019, But Lack Systems and Expertise for This Task

Medicare officials are including most hospital laboratories in this PAMA data reporting cycle, but hospitals face $10,000/day federal penalties for not filing, filing late, or filing incomplete or inaccurate data Clinical laboratories operated by hospitals and health systems could prove to be a game changer for the lab industry in this upcoming PAMA private payer lab test price reporting cycle. But that upside comes with risk. For this reporting period, the federal Centers for Medicare and...

Implementing a New EHR at the Veterans Administration Is Taking Longer and Costing More than Earlier Estimates

With a now-estimated price tag of $16.1 billion, federal regulators and government representatives question the VA’s replacement for their VistA medical records system Originally estimated to cost $10 billion, a contract to replace the federal Department of Veterans Affairs (VA) electronic health record (EHR) system will now cost $16.1 billion, according to new estimates, and this has drawn increased scrutiny from regulators and the media. ProPublica reports that the initial deal signed in May...

New CMS Final Rule Makes Clinical Laboratory Test/Procedure Pricing Listed on Hospital Chargemasters Available to Public

Experts are skeptical of the value of public price lists based on hospital chargemasters due to complexity and poor reflection of actual costs In another big step toward helping consumers view prices of medical procedures when selecting providers, the Centers for Medicare and Medicaid Services (CMS) passed the IPPS/LTCH PPS final rule, which requires hospitals to post a full list of hospital pricing information on their websites starting January 1, 2019. Clinical laboratories, anatomic...